美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

First Trust Indxx Medical Devices ETF

20.43

+0.05480.27%

盤後：20.430.00000.00%16:10 EDT

成交量：123

成交額：2,532

市值：306.52萬

市盈率：- -

高：20.50

開：20.50

低：20.43

收：20.38

52周最高：21.82

52周最低：17.85

股本：15.00萬

流通股本：15.00萬

量比：0.15

換手率：0.08%

股息：0.02

股息率：0.11%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

國信證券：腔鏡手術機器人國產崛起進口替代與出海並進

國信證券：腔鏡手術機器人國產崛起進口替代與出海並進

中信建投：建議關注創新醫療器械的臨床、註冊、放量、出海等方面的相關催化

中信建投：建議關注創新醫療器械的臨床、註冊、放量、出海等方面的相關催化

上海：支持企業研發的創新藥、現代中藥和高端醫療器械全球註冊認證並在當地實現銷售

上海市藥品監督管理局批准註冊28項醫療器械產品

葵花葯業投資成立醫藥公司

華東醫藥(000963.SZ)子公司醫療器械獲得歐盟MDR CE認證

浙江推進醫療器械臨床創新成果轉化

創新、出海雙線驅動醫療器械產業升級！醫療器械ETF華泰柏瑞（561810）助力把握板塊業績估值修復機遇

搶銅潮擾動全球供應鏈 AI基建擴張之下算力金屬供應承壓

昊海生物科技(06826.HK)控股子公司三焦點環曲面人工晶狀體產品獲得醫療器械註冊證

達安基因：下屬子公司取得一個醫療器械註冊證

東方海洋：子公司獲兒茶酚胺代謝譜檢測試劑盒醫療器械註冊證

天智航：取得骨科手術計劃軟件醫療器械註冊證

中泰證券：腔鏡手術機器人正處於滲透率曲線早期國產商業化與出海迎收穫期

科華生物：淋球菌核酸檢測試劑盒獲醫療器械註冊證

透景生命：取得醫療器械變更註冊文件及多項註冊申請獲受理

新華醫療：產品獲三類和二類醫療器械註冊證

天智航「蛇吞象式」收購拖累報表？三大疑問待解遭投資者用腳投票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/MDEV/news?page=7"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MDEV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MDEV\",,,,,undefined,":{"symbol":"MDEV","market":"US","secType":"STK","nameCN":"First Trust Indxx Medical Devices ETF","latestPrice":20.4347,"timestamp":1789588800000,"preClose":20.3799,"halted":0,"volume":123,"hourTrading":{"tag":"盘后","latestPrice":20.4347,"preClose":20.4347,"latestTime":"16:10 EDT","volume":6,"amount":122.6082,"timestamp":1789589404309,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.0026889238906962344,"floatShares":150002,"shares":150002,"eps":0,"marketStatus":"盤後交易","change":0.0548,"latestTime":"09-16 19:57:57 EDT","open":20.5,"high":20.5,"low":20.4347,"amount":2532,"amplitude":0.003204,"askPrice":23.77,"askSize":100,"bidPrice":15.32,"bidSize":200,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1789603200000},"marketStatusCode":4,"adr":0,"exchange":"CBOE","adjPreClose":20.3799,"sharesOutstanding":100002,"nav":20.48,"aum":3072040.96,"dividendRate":0.001096,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":20.4347,"preClose":20.4347,"latestTime":"16:10 EDT","volume":6,"amount":122.6082,"timestamp":1789589404309,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.154097,"impliedVol":0.3604,"impliedVolPercentile":0.6335},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MDEV\",,,,,undefined,":{"symbol":"MDEV","floatShares":150002,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.154097,"shares":150002,"dividePrice":0.0224,"high":20.5,"amplitude":0.003204,"preClose":20.3799,"low":20.4347,"week52Low":17.8532,"pbRate":"--","week52High":21.82,"institutionHeld":0,"latestPrice":20.4347,"committee":0.333333,"eps":0,"divideRate":0.001096,"volume":123,"delay":0,"ttmEps":0,"open":20.5,"prevYearClose":21.117,"prevWeekClose":20.0179,"prevMonthClose":21.2998,"prevQuarterClose":19.1533,"fiveDayClose":20.3539,"twentyDayClose":21.248,"sixtyDayClose":18.4842},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MDEV\",params:#limit:5,,,undefined,":[{"date":"2026-06-25","symbol":"MDEV","amount":0.0217,"announcedDate":"2026-06-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-25","defaultRemindTime":1782394200000,"name":"First Trust Indxx Medical Devices ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-25","currency":"USD","dateTimestamp":1782360000000,"payDate":"2026-06-30"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MDEV\",market:\"US\",,,undefined,":[{"executeDate":"2026-06-25","recordDate":"2026-06-25","paymentDate":"2026-06-30","value":0.0217,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MDEV\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MDEV\",pageSize:20,pageCount:7,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658961354","title":"國信證券：腔鏡手術機器人國產崛起 進口替代與出海並進","url":"https://stock-news.laohu8.com/highlight/detail?id=2658961354","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658961354?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 12:28","pubTimestamp":1786422529,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["HTEC","MDEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658969525","title":"國信證券：腔鏡手術機器人國產崛起 進口替代與出海並進","url":"https://stock-news.laohu8.com/highlight/detail?id=2658969525","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658969525?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 11:30","pubTimestamp":1786419031,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，国信证券发布研报称，腔镜手术机器人是手术机器人商业化最成熟、临床确定性最强的核心赛道，行业由进口绝对主导转向国产多元竞争。国产手术机器人出海进入加速期全球腔镜手术机器人长期由直觉外科达芬奇系统垄断，2024年全球多孔腔镜机器人销量中市占率高达83%，但其在新兴市场面临采购及维护成本高昂、本地化服务不足等天然痛点，为国产企业留出差异化窗口。国产手术机器人出海正迈入加速期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1478372.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0276","HTEC","002736","BK0183","MDEV","BK0188","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658500149","title":"中信建投：建議關注創新醫療器械的臨床、註冊、放量、出海等方面的相關催化","url":"https://stock-news.laohu8.com/highlight/detail?id=2658500149","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658500149?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 08:07","pubTimestamp":1786406879,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["AGNG","159883","HART","MDEV","09996","PTH","LGHT","IEIH","MEDX","601066","BK1100","BK1583","BK1574","LNGR","RSPH","GDOC","BK0276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658095001","title":"中信建投：建議關注創新醫療器械的臨床、註冊、放量、出海等方面的相關催化","url":"https://stock-news.laohu8.com/highlight/detail?id=2658095001","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658095001?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 08:06","pubTimestamp":1786406784,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["AGNG","LNGR","LGHT","GDOC","IEIH","MDEV","PTH","HART","RSPH","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658981293","title":"上海：支持企業研發的創新藥、現代中藥和高端醫療器械全球註冊認證並在當地實現銷售","url":"https://stock-news.laohu8.com/highlight/detail?id=2658981293","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658981293?lang=zh_tw&edition=fundamental","pubTime":"2026-08-10 17:08","pubTimestamp":1786352902,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["AGNG","HART","MDEV","GDOC","09996","159992","PTH","06978","LNGR","BK1100","BK1583","BK1574","BK1161","RSPH","MEDX","159883","IEIH","IBBQ","LGHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658260288","title":"上海市藥品監督管理局批准註冊28項醫療器械產品","url":"https://stock-news.laohu8.com/highlight/detail?id=2658260288","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658260288?lang=zh_tw&edition=fundamental","pubTime":"2026-08-10 12:05","pubTimestamp":1786334738,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MDEV","LNGR","AGNG","IEIH","MEDX","LGHT","GDOC","PTH","HART","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658604034","title":"葵花葯業投資成立醫藥公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2658604034","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658604034?lang=zh_tw&edition=fundamental","pubTime":"2026-08-10 12:00","pubTimestamp":1786334411,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LNGR","LGHT","IEIH","PTH","MEDX","GDOC","AGNG","HART","RSPH","MDEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658674572","title":"華東醫藥(000963.SZ)子公司醫療器械獲得歐盟MDR CE認證","url":"https://stock-news.laohu8.com/highlight/detail?id=2658674572","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658674572?lang=zh_tw&edition=fundamental","pubTime":"2026-08-09 16:37","pubTimestamp":1786264666,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华东医药 发布公告，近日，公司英国全资子公司Sinclair Pharma Limited旗下一款全新专利成分的注射用羧甲基壳聚糖溶液KIO015获得欧盟MDR CE认证，取得欧盟市场上市准入资格，系全球首款且目前唯一一款创新型非动物源性壳聚糖医美注射产品。该产品已取得欧盟MDR CE认证，尚未取得国内医疗器械注册证，目前亦未实际形成销售收入。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1477684.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IEIH","09996","PSCM","BK4585","LU2328871848.SGD","BK0183","MDEV","000963","CE","LNGR","BK0132","BK0209","GDOC","BK4588","BK1100","BK0175","BK0188","FSXEmain","FESXmain","BK4109","159883","BK0196","BK1583","HART","AGNG","BK0187","LU1969619763.USD","MEDX","LGHT","BK1574","RSPH","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658674336","title":"浙江推進醫療器械臨床創新成果轉化","url":"https://stock-news.laohu8.com/highlight/detail?id=2658674336","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658674336?lang=zh_tw&edition=fundamental","pubTime":"2026-08-09 16:08","pubTimestamp":1786262935,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LGHT","HART","PTH","GDOC","AGNG","LNGR","RSPH","MDEV","IEIH","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657621656","title":"創新、出海雙線驅動醫療器械產業升級！醫療器械ETF華泰柏瑞（561810）助力把握板塊業績估值修復機遇","url":"https://stock-news.laohu8.com/highlight/detail?id=2657621656","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657621656?lang=zh_tw&edition=fundamental","pubTime":"2026-08-07 08:31","pubTimestamp":1786062660,"startTime":"0","endTime":"0","summary":"在医疗器械行业景气度逐步回升、产业格局持续优化的关键窗口，华泰柏瑞基金旗下的医疗器械ETF华泰柏瑞于2026年8月7日正式上市，为助力投资者把握板块修复机遇提供便捷工具。与此同时，经过前期板块持续调整，医疗器械ETF华泰柏瑞的标的指数中证全指医疗器械指数最新市盈率回落至41.82倍，处于发布以来43.5%的历史分位，整体估值位于合理偏低区间。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-08-07/doc-inimmyer3306212.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IEIH","LCO","09996","CZA","159898","MDEV","LNGR","GDOC","159891","BK1100","NIFE","159883","BK1583","HART","AGNG","MEDX","LGHT","BK1574","RSPH","PTH","REVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657266101","title":"搶銅潮擾動全球供應鏈 AI基建擴張之下算力金屬供應承壓","url":"https://stock-news.laohu8.com/highlight/detail?id=2657266101","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657266101?lang=zh_tw&edition=fundamental","pubTime":"2026-08-07 07:22","pubTimestamp":1786058524,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MDEV","VTHR","APLY","AAPX","SUPP","AAPY","AAPU","AIPO","AAPD","AGIX","BK4535","AAPB","XME","QTOC","AAPW","ARTY","SHPP","SUPL","CHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657822687","title":"昊海生物科技(06826.HK)控股子公司三焦點環曲面人工晶狀體產品獲得醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2657822687","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657822687?lang=zh_tw&edition=fundamental","pubTime":"2026-08-06 18:31","pubTimestamp":1786012276,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MDEV","LNGR","MEDX","RSPH","HART","LGHT","IEIH","PTH","AGNG","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657689251","title":"達安基因：下屬子公司取得一個醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2657689251","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657689251?lang=zh_tw&edition=fundamental","pubTime":"2026-08-06 17:20","pubTimestamp":1786008000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LGHT","HART","PTH","GDOC","AGNG","LNGR","RSPH","MDEV","IEIH","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657868990","title":"東方海洋：子公司獲兒茶酚胺代謝譜檢測試劑盒醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2657868990","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657868990?lang=zh_tw&edition=fundamental","pubTime":"2026-08-06 17:08","pubTimestamp":1786007311,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IEIH","RSPH","LGHT","MEDX","GDOC","AGNG","LNGR","HART","MDEV","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657686225","title":"天智航：取得骨科手術計劃軟件醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2657686225","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657686225?lang=zh_tw&edition=fundamental","pubTime":"2026-08-06 16:53","pubTimestamp":1786006419,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["AGNG","VGT","BK4585","MEDX","GDOC","HART","IEIH","MDEV","BK4588","LNGR","RSPH","LGHT","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657508099","title":"中泰證券：腔鏡手術機器人正處於滲透率曲線早期 國產商業化與出海迎收穫期","url":"https://stock-news.laohu8.com/highlight/detail?id=2657508099","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657508099?lang=zh_tw&edition=fundamental","pubTime":"2026-08-06 09:35","pubTimestamp":1785980121,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中泰证券发布研报称，中国腔镜手术机器人行业正处于渗透率曲线的早期阶段，国产企业硬件性能基本拉平、在远程手术上差异化领跑，当前国内公开招标数据已反超进口，叠加出海打开第二增长曲线，头部公司正迈入商业化兑现期。同时，国内市场渗透率仍处于极低水平，2024年中国机器人辅助腔镜手术渗透率仅为0.7%，提升空间广阔，预计2035年将达到人民币337亿元，其中单孔增速更快。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1476598.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0276","MDEV","HTEC","600918"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657491445","title":"科華生物：淋球菌核酸檢測試劑盒獲醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2657491445","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657491445?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 19:33","pubTimestamp":1785929597,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["AGNG","MEDX","GDOC","HART","IEIH","MDEV","LNGR","RSPH","LGHT","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657066545","title":"透景生命：取得醫療器械變更註冊文件及多項註冊申請獲受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2657066545","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657066545?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 19:03","pubTimestamp":1785927812,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["RSPH","HART","AGNG","LNGR","MEDX","MDEV","IEIH","GDOC","LGHT","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657519883","title":"新華醫療：產品獲三類和二類醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2657519883","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657519883?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 15:33","pubTimestamp":1785915193,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["AGNG","MEDX","GDOC","HART","IEIH","MDEV","LNGR","RSPH","LGHT","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656329169","title":"天智航「蛇吞象式」收購拖累報表？三大疑問待解 遭投資者用腳投票","url":"https://stock-news.laohu8.com/highlight/detail?id=2656329169","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656329169?lang=zh_tw&edition=fundamental","pubTime":"2026-08-03 15:46","pubTimestamp":1785743160,"startTime":"0","endTime":"0","summary":"近日，天智航“蛇吞象式”收购复牌似乎遭投资者用脚投票，公司复牌第一个交易日收跌，当日跌幅为8.85%。截至此次预案签署日，此次交易的审计及评估工作尚未完成，标的资产估值及定价尚未确定。本次交易预计将达到《重组管理办法》规定的重大资产重组标准，从而构成上市公司重大资产重组。收购拖累报表叙事不性感？截止一季度末，天智航账面资金不足2亿元，资产负债率低于30%。若未来将其并表，是否可能进一步拖累天智航报表？","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/observe/2026-08-03/doc-inikzqsr2765691.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["MDEV","LABU","KOMP","BK4585","BK4588","ROBO","PBOT","HTEC"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}]}}